Global Malignant Melanoma Drug Market to Grow Swiftly, Predicts Kuick Research in Its New Report Available at MarketPublishers.com20 May 2016 • by Natalie Aster
LONDON – Surgery is often used to treat malignant melanoma and other types of cancer. Radiation therapy is also used to treat the melanoma. However, it has long-term deleterious effects on a body.
Malignant cancer can be prevented by the chemotherapeutics, but side effects of chemotherapeutics increase morbidity and effects decrease a quality of life of patients.
At present, investigators focus on development of innovative therapeutics for treatment of malignant melanoma with high efficacy and safety, and growing incidence is one of major reasons for the increase in R&D activities.
A large number of clinical trials aimed at finding an effective therapeutics have been carried out over the last few years.
There are many products are currently in different stages of development, and they are expected to be introduced in the upcoming years. This will lead to significant growth of the global market for malignant melanoma.
New research report “Global Malignant Melanoma Drug Market & Clinical Pipeline Insight” developed by Kuick Research offers a comprehensive discussion of the global malignant melanoma marketplace. The study provides an all-round overview of this type of cancer. It covers drug mechanism of action for melanoma and concentrates on the current market scenario.
The report comprises a thorough overview of the malignant melanoma pipeline. It scrutinizes dynamics of this marketplace and analyzes the clinical pipeline on the basis of companies and phases.
The research study contains an in-depth clinical insight into marketed drugs and explores the competitive landscape. Forecast figures can be also found in the report.
Companies mentioned in the study comprise: BioVex, Exelixis, Array BioPharma, Ono Pharmaceutical, Reliance Life Sciences, GlaxoSmithKline, AB Science, and more.
Other Marketplaces Examined by the Publisher Include:
More new reports by our market research partner are available at Kuick Research page.